July 19, 2016

Helmsley-Salk fellow garners prestigious microscopy award

Salk Nachrichten


Helmsley-Salk fellow garners prestigious microscopy award

2125-lyumkis
Dmitri Lyumkis

Klicken Sie hier for a high-resolution image

Kredit: Salk Institut

Helmsley-Salk Fellow Dmitri Lyumkis has been awarded the 2016 George Palade Award by the Microscopy Society of America. The award is given for distinguished contributions to the field of microscopy and microanalysis in the life sciences of an early career scientist.

Lyumkis was recognized for his work using and developing single-particle cryo-electron microscopy to understand the biological complexity characterized by large macromolecules and macromolecular assemblies. Much of his lab’s effort is geared toward the structural characterization of HIV-1 proteins. Through observing their structure under various physiological conditions, he hopes to gain deeper insight into the complex roles macromolecules play in HIV and other human diseases such as Krebs.

The George Palade Award was named after Romanian-American cell biologist George Emil Palade, who received the Nobel Prize in Physiology or Medicine in 1974. With a membership of about 3,000, the Microscopy Society of America (MSA) is a nonprofit organization dedicated to the promotion and advancement of techniques and applications of microscopy and microanalysis in all relevant scientific disciplines.

Forschungsbereiche

Für weitere Informationen

Büro für Kommunikation
Telefon: (858) 453-4100
press@salk.edu

Das Salk-Institut für biologische Studien:

Das Salk Institute ist ein unabhängiges, gemeinnütziges Forschungsinstitut, das 1960 von Jonas Salk, dem Entwickler des ersten sicheren und wirksamen Polio-Impfstoffs, gegründet wurde. Die Aufgabe des Instituts besteht darin, grundlegende, kooperative und risikofreudige Forschung voranzutreiben, die sich mit den dringendsten Herausforderungen der Gesellschaft befasst, darunter Krebs, Alzheimer und die Gefährdung der Landwirtschaft. Diese Grundlagenforschung bildet die Basis für alle translationalen Bemühungen und führt zu Erkenntnissen, die neue Medikamente und Innovationen weltweit ermöglichen.